We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

156 hedge funds and large institutions have $909M invested in Arcturus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 16

65% more call options, than puts

Call options by funds: $22.8M | Put options by funds: $13.8M

31% more capital invested

Capital invested by funds: $694M → $909M (+$215M)

14% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 42

12% more funds holding

Funds holding: 139 → 156 (+17)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5.5% less ownership

Funds ownership: 77.91% → 72.41% (-5.5%)

Holders
156
Holders Change
+17
Holders Change %
+12.23%
% of All Funds
2.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
34
Increased
48
Reduced
42
Closed
16
Calls
$22.8M
Puts
$13.8M
Net Calls
+$8.98M
Net Calls Change
+$10.8M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.4M
2
NAMA
Nikko Asset Management Americas
New York
+$6.44M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$6.44M
4
Millennium Management
Millennium Management
New York
+$3.99M
5
IHAM
Integral Health Asset Management
New York
+$3.81M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$28.7M
2
AIM
ARK Investment Management
Florida
-$15.9M
3
Two Sigma Investments
Two Sigma Investments
New York
-$14.3M
4
State Street
State Street
Massachusetts
-$12.8M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
126
Macquarie Group
Australia
$14K – – –
DFCM
127
Dark Forest Capital Management
Puerto Rico
$14K +$13.4K +299 New
OSNBOA
128
Old Second National Bank of Aurora
Illinois
$10K – – –
PWA
129
Phoenix Wealth Advisors
North Carolina
$10K – – –
HI
130
Harbour Investments
Wisconsin
$10K +$314 +7 +3%
AF
131
Advisornet Financial
Minnesota
$10K +$8.96K +200 New
Koshinski Asset Management
132
Koshinski Asset Management
Illinois
$9.56K +$8.96K +200 New
First Manhattan
133
First Manhattan
New York
$9K – – –
Rockefeller Capital Management
134
Rockefeller Capital Management
New York
$8K -$672 -15 -8%
EWM
135
Endurance Wealth Management
Rhode Island
$8K – – –
CFA
136
Carroll Financial Associates
North Carolina
$6K – – –
CMBA
137
C.M. Bidwell & Associates
Hawaii
$6K – – –
LWANC
138
Laurel Wealth Advisors (North Carolina)
North Carolina
$6K – – –
SIC
139
Salem Investment Counselors
North Carolina
$5K – – –
SBL
140
Sargent Bickham Lagudis
Colorado
$5K +$4.48K +100 New
BFG
141
Baron Financial Group
New Jersey
$4.78K – – –
QCG
142
Quadrant Capital Group
Ohio
$4K +$3.54K +79 New
RE
143
RBC Europe
United Kingdom
$3.49K – – –
TWA
144
TCI Wealth Advisors
Arizona
$3K – – –
CAPTRUST Financial Advisors
145
CAPTRUST Financial Advisors
North Carolina
$2K -$717 -16 -31%
JMF
146
Johnson Midwest Financial
Iowa
$2K – – –
PCFFS
147
Pacific Center for Financial Services
California
$2K – – –
S
148
SignatureFD
Georgia
$2K +$538 +12 +38%
CA
149
Clearstead Advisors
Ohio
$1K – – –
IF
150
Ironwood Financial
Arizona
$1K – – –
3 4 5
6
7

ARCT Hedge Fund Activity: Q3 2021 in Review

156 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q3 2021, worth a combined $909M — up 31% from $694M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARCT positions and 16 closed out — a net gain of 18 holders — while 48 added to existing stakes and 42 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $15.4M. The largest seller was OrbiMed, exiting entirely with an estimated $28.7M sold.

  • 156 institutional investors held Arcturus Therapeutics (ARCT) as of Q3 2021, up from 139 in Q2 2021.
  • Funds reported $909M of Arcturus Therapeutics stock for Q3 2021, up 31% quarter-over-quarter.
  • 34 funds opened new Arcturus Therapeutics positions in Q3 2021 and 16 closed out, a net change of +18 holders.
  • The largest Arcturus Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $15.4M added.
  • The largest Arcturus Therapeutics seller in Q3 2021 was OrbiMed, an estimated $28.7M sold.

Based on aggregated 13F filings for Q3 2021.